Compare Elder Pharma with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA SHASUN PHARMA ELDER PHARMA/
SHASUN PHARMA
 
P/E (TTM) x -0.2 123.9 - View Chart
P/BV x 0.1 8.5 1.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 ELDER PHARMA   SHASUN PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
SHASUN PHARMA
Mar-14
ELDER PHARMA/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs38094 403.4%   
Low Rs18846 412.3%   
Sales per share (Unadj.) Rs491.2214.2 229.3%  
Earnings per share (Unadj.) Rs-3.25.3 -59.6%  
Cash flow per share (Unadj.) Rs14.415.8 91.1%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs376.553.3 705.8%  
Shares outstanding (eoy) m20.5456.62 36.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.60.3 177.2%   
Avg P/E ratio x-89.313.1 -681.4%  
P/CF ratio (eoy) x19.74.4 446.1%  
Price / Book Value ratio x0.81.3 57.6%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m5,8333,958 147.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1792,164 100.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,08912,127 83.2%  
Other income Rs m257229 111.9%   
Total revenues Rs m10,34612,356 83.7%   
Gross profit Rs m-7921,009 -78.5%  
Depreciation Rs m361594 60.9%   
Interest Rs m2,756415 664.0%   
Profit before tax Rs m-3,653230 -1,590.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125-73 -172.1%   
Profit after tax Rs m-65302 -21.6%  
Gross profit margin %-7.88.3 -94.3%  
Effective tax rate %-3.4-31.7 10.8%   
Net profit margin %-0.62.5 -26.0%  
BALANCE SHEET DATA
Current assets Rs m9,2406,884 134.2%   
Current liabilities Rs m9,9988,456 118.2%   
Net working cap to sales %-7.5-13.0 57.9%  
Current ratio x0.90.8 113.5%  
Inventory Days Days4662 75.1%  
Debtors Days Days60108 55.7%  
Net fixed assets Rs m10,1244,970 203.7%   
Share capital Rs m206113 181.6%   
"Free" reserves Rs m5,5822,875 194.2%   
Net worth Rs m7,7343,020 256.1%   
Long term debt Rs m4,8891,817 269.0%   
Total assets Rs m22,88213,347 171.4%  
Interest coverage x-0.31.6 -20.9%   
Debt to equity ratio x0.60.6 105.1%  
Sales to assets ratio x0.40.9 48.5%   
Return on assets %11.85.4 218.8%  
Return on equity %-0.810.0 -8.4%  
Return on capital %22.313.3 167.5%  
Exports to sales %3.046.4 6.6%   
Imports to sales %0.414.2 3.0%   
Exports (fob) Rs m3075,622 5.5%   
Imports (cif) Rs m431,728 2.5%   
Fx inflow Rs m3075,843 5.2%   
Fx outflow Rs m1252,173 5.8%   
Net fx Rs m1813,669 4.9%   
CASH FLOW
From Operations Rs m11,754398 2,956.3%  
From Investments Rs m-561-1,635 34.3%  
From Financial Activity Rs m-6,7621,309 -516.7%  
Net Cashflow Rs m4,43271 6,224.3%  

Share Holding

Indian Promoters % 39.6 39.2 101.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 3.6 208.3%  
FIIs % 16.8 17.6 95.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 39.6 91.2%  
Shareholders   16,479 20,750 79.4%  
Pledged promoter(s) holding % 77.6 12.3 631.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   AUROBINDO PHARMA  DR. REDDYS LAB  NOVARTIS  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS